Cargando…

NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells

Purpose: The NLRP3 inflammasome activation has been proposed as a common mechanism for some adjuvants to boost the immune system, and cationic liposomes were reported to potentially activate the NLRP3 inflammasome. Herein, we questioned whether the NLRP3 inflammasome-activating cationic liposomes co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianshu, Zehner, Matthias, He, Jieyan, Próchnicki, Tomasz, Horvath, Gabor, Latz, Eicke, Burgdorf, Sven, Takeoka, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526778/
https://www.ncbi.nlm.nih.gov/pubmed/31190807
http://dx.doi.org/10.2147/IJN.S202379
_version_ 1783419954471632896
author Li, Tianshu
Zehner, Matthias
He, Jieyan
Próchnicki, Tomasz
Horvath, Gabor
Latz, Eicke
Burgdorf, Sven
Takeoka, Shinji
author_facet Li, Tianshu
Zehner, Matthias
He, Jieyan
Próchnicki, Tomasz
Horvath, Gabor
Latz, Eicke
Burgdorf, Sven
Takeoka, Shinji
author_sort Li, Tianshu
collection PubMed
description Purpose: The NLRP3 inflammasome activation has been proposed as a common mechanism for some adjuvants to boost the immune system, and cationic liposomes were reported to potentially activate the NLRP3 inflammasome. Herein, we questioned whether the NLRP3 inflammasome-activating cationic liposomes could promote antigen presentation and be applied as an immune adjuvant. In addition, we aimed to investigate the structure effect of lipid on triggering these immune responses. Materials and methods: A series of structurally similar lipids, consisting of arginine (Arg) head group and varied lengths of alkyl chains or spacers in between were used to prepare cationic liposomes. Lipopolysaccharide-primed human or murine macrophages or phorbol 12-myristate 13-acetate-primed THP-1 cells were treated with these liposomes, and interleukin (IL)-1β secretion was measured to quantify the NLRP3 inflammasome activation. Lysosome rupture was examined in THP-1 cells by the fluorescence loss of acridine orange, a lysosome dye. Further, chicken ovalbumin (OVA) was loaded on the liposome surface and applied to murine bone marrow-derived dendritic cells (BMDCs), which activate OT-I and OT-II lymphocytes upon major histocompatibility complex (MHC) class I- and class II-mediated antigen presentation, respectively. OT-I and OT-II cell division and IL-2 secretion were measured to evaluate the antigen presentation efficiency. The expressions of MHC molecules and co-stimulatory molecules ie, CD80, CD86, and CD40 on BMDCs were investigated by flow cytometry. Results: All the liposomes showed size distributions of 80–200 nm and zeta potentials of around 50 mV. A3C14 liposomes, consisting of Arg-C3-Glu2C14 lipids induced the most potent lysosome rupture and NLRP3 inflammasome activation. OVA-A3C14 also exhibited the most potent MHC class I- and class II-mediated antigen presentation in BMDCs without interfering MHC and co-stimulatory molecules. Conclusion: The hydrophobic moieties of arginine-based liposomes are crucial in stimulating innate immune cells. A3C14 liposomes were non-immunogenic but strongly activated innate immune cells and promoted antigen presentation, and therefore can be applied as immune adjuvants.
format Online
Article
Text
id pubmed-6526778
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65267782019-06-12 NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells Li, Tianshu Zehner, Matthias He, Jieyan Próchnicki, Tomasz Horvath, Gabor Latz, Eicke Burgdorf, Sven Takeoka, Shinji Int J Nanomedicine Original Research Purpose: The NLRP3 inflammasome activation has been proposed as a common mechanism for some adjuvants to boost the immune system, and cationic liposomes were reported to potentially activate the NLRP3 inflammasome. Herein, we questioned whether the NLRP3 inflammasome-activating cationic liposomes could promote antigen presentation and be applied as an immune adjuvant. In addition, we aimed to investigate the structure effect of lipid on triggering these immune responses. Materials and methods: A series of structurally similar lipids, consisting of arginine (Arg) head group and varied lengths of alkyl chains or spacers in between were used to prepare cationic liposomes. Lipopolysaccharide-primed human or murine macrophages or phorbol 12-myristate 13-acetate-primed THP-1 cells were treated with these liposomes, and interleukin (IL)-1β secretion was measured to quantify the NLRP3 inflammasome activation. Lysosome rupture was examined in THP-1 cells by the fluorescence loss of acridine orange, a lysosome dye. Further, chicken ovalbumin (OVA) was loaded on the liposome surface and applied to murine bone marrow-derived dendritic cells (BMDCs), which activate OT-I and OT-II lymphocytes upon major histocompatibility complex (MHC) class I- and class II-mediated antigen presentation, respectively. OT-I and OT-II cell division and IL-2 secretion were measured to evaluate the antigen presentation efficiency. The expressions of MHC molecules and co-stimulatory molecules ie, CD80, CD86, and CD40 on BMDCs were investigated by flow cytometry. Results: All the liposomes showed size distributions of 80–200 nm and zeta potentials of around 50 mV. A3C14 liposomes, consisting of Arg-C3-Glu2C14 lipids induced the most potent lysosome rupture and NLRP3 inflammasome activation. OVA-A3C14 also exhibited the most potent MHC class I- and class II-mediated antigen presentation in BMDCs without interfering MHC and co-stimulatory molecules. Conclusion: The hydrophobic moieties of arginine-based liposomes are crucial in stimulating innate immune cells. A3C14 liposomes were non-immunogenic but strongly activated innate immune cells and promoted antigen presentation, and therefore can be applied as immune adjuvants. Dove 2019-05-13 /pmc/articles/PMC6526778/ /pubmed/31190807 http://dx.doi.org/10.2147/IJN.S202379 Text en © 2019 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Tianshu
Zehner, Matthias
He, Jieyan
Próchnicki, Tomasz
Horvath, Gabor
Latz, Eicke
Burgdorf, Sven
Takeoka, Shinji
NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
title NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
title_full NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
title_fullStr NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
title_full_unstemmed NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
title_short NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
title_sort nlrp3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526778/
https://www.ncbi.nlm.nih.gov/pubmed/31190807
http://dx.doi.org/10.2147/IJN.S202379
work_keys_str_mv AT litianshu nlrp3inflammasomeactivatingargininebasedliposomespromoteantigenpresentationsindendriticcells
AT zehnermatthias nlrp3inflammasomeactivatingargininebasedliposomespromoteantigenpresentationsindendriticcells
AT hejieyan nlrp3inflammasomeactivatingargininebasedliposomespromoteantigenpresentationsindendriticcells
AT prochnickitomasz nlrp3inflammasomeactivatingargininebasedliposomespromoteantigenpresentationsindendriticcells
AT horvathgabor nlrp3inflammasomeactivatingargininebasedliposomespromoteantigenpresentationsindendriticcells
AT latzeicke nlrp3inflammasomeactivatingargininebasedliposomespromoteantigenpresentationsindendriticcells
AT burgdorfsven nlrp3inflammasomeactivatingargininebasedliposomespromoteantigenpresentationsindendriticcells
AT takeokashinji nlrp3inflammasomeactivatingargininebasedliposomespromoteantigenpresentationsindendriticcells